New sulfonamide and sulfonic ester porphyrins as sensitizers for photodynamic therapy

Journal of Porphyrins and Phthalocyanines

Volumn 6, Issue 7-8, 2002, Pages 456-462

  Sobrala, Abilio J F N ^a   Eléouet, Sabine ^b   Rousset, Nathalie ^b   Rocha Gonsalves, António M d'A ^a   Le Meur, Olivier ^b   Bourré, Ludovic ^b   Patrice, Thierry ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CHU de Nantes   (France)

Author keywords

Photodynamic therapy; Porphyrins; Sulfonamides; Sulfonic esters

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; SULFONAMIDE; SULFONIC ESTER PORPHYRIN; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIZATION; FLUORESCENCE; ILLUMINATION; MORTALITY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0036975453     PISSN: 10884246     EISSN: None     Source Type: Journal    
DOI: 10.1142/s1088424602000567     Document Type: Article

References (27)

1. a) Richardson T, Smith VC, Johnstone RAW, Sobral AJFN and Rocha-Gonsalves AmdA. Thin Solid Films 1998; 327-329: 315-320.
2. b) Salhi S, Koulikov SG, Bied-Charreton C and Galaup JP. J. Lumin. 1998; 78: 187-195.
3. c) Fox MA. Acc. Chem. Res. 1999; 32: 201-207.
4. d) Liu C-Y and Bard AJ. Acc. Chem. Res. 1999; 32: 235-245.
5. e) Drobizhev M, Sigel C and Rebane A. J. Lumin. 2000; 86: 391-397.
6. a) Bonnett R. Chem. Soc. Rev. 1995; 24: 19-33.
7. b) Sternberg ED, Dolphin D and Bruckner C. Tetrahedron 1998; 54: 4151-4202.
8. c) Bonnett R. Chemicals Aspects of Photodynamic Therapy in Advanced Chemistry Texts Series; Gordon and Breach Science Publishers: Amsterdam, 2000; Vol. 1; p 324.
9. d) Konan YN, Gurny R and Allemann E. J. Photochem. Photobiol., B 2002; 66: 89-106.
10. a) Elslager EF, Colbry NL, Davoll J, Hutt MP, Johnson JL and Werbel LM. J. Med. Chem. 1984; 27: 1740-1743.
11. b) Tome AC, Cavaleiro JAS, Domingues FMJ and Cremlyn RJ. Phosphorus, Sulfur Silicon Relat. Elem. 1993; 79: 187-194.
12. c) Liegeois JF, Dive G, Dupont L and Delarge J. Helv. Chim. Acta 1991; 74: 1764-1772.
13. d) Moree WJ, Van Gent LC, Van der Marel GA and Liskamp RMJ. Tetrahedron 1993; 49: 1133-1150.
14. e) Beaver KA, Siegmund AC and Spear KL. Tetrahedron Lett. 1996; 37: 1145-1148.
15. f) Johnson DC and Widlanski TS. Tetrahedron Lett. 2001; 42: 3677-3679.
16. g) Bharatam PV, Amita AG and Kaur D. Tetrahedron 2002; 58: 1759-1764.
17. Figge FHJ, Carey TN and Weiland GS. J. Lab. Clin. Med. 1946; 31: 752-756.
18. a) Adler AD, Longo FR, Finarelli JD, Goldmacher J, Assour J and Korsakoff L. J. Org. Chem. 1967; 32: 476.
19. b) Barnett GH, Hudson MF and Smith KM. J. Chem. Soc., Perkin Trans. 1 1975: 1401-1403.
20. Gonsalves AMdAR, Johnstone RAW, Pereira MM, de SantAna AMP, Serra AC, Sobral AJFN and Stocks PA. Heterocycles 1996; 43: 829-838.
21. Mosmann T. J. Immunol. Methods 1983; 65: 55-63.
22. Vonarx V, Cordel S, Lenz P, Foultier MT, Pottier R, Kennedy J and Patrice T. J. Phys. IV 1994; 4: 199-202.
23. Eleouet S, Carre J, Vonarx V, Heyman D, Lajat Y and Patrice T. J. Photochem. Photobiol., B 1997; 41: 22-29.
24. Jori G. J. Photochem. Photobiol., B 1996; 36: 87-93.
25. Vonarx V, Foultier MT, Anasagasti L, Morlet L, Lajat Y and Patrice T. Int. J. Immunopharmacol. 1997; 19: 101-110.
26. Vonarx-Coinsmann V, Foultier M-T, Cempel N, Morlet L, Combre A and Patrice T. Lasers Med. Sci. 1994; 9: 173.
27. Rousset N, Vonarx V, Eleouet S, Carre J, Bourre L, Lajat Y and Patrice T. Res. Exp. Med. 2000; 199: 341-357.